-
Mashup Score: 2
This analysis suggests serum IL-13 levels are lower in bullous pemphigoid patients than in healthy controls and pemphigus vulgaris patients.
Source: www.hcplive.comCategories: General Medicine NewsTweet
-
Mashup Score: 1
This analysis suggests serum IL-13 levels are lower in bullous pemphigoid patients than in healthy controls and pemphigus vulgaris patients.
Source: www.hcplive.comCategories: General Medicine NewsTweet-
New findings suggest that while serum IL-13 levels are lower in patients with #BullousPemphigoid compared to healthy controls, IL-13 levels do not correlate with bullous pemphigoid severity or prognosis. View more: https://t.co/0dBRWvZ1ww
-
-
Mashup Score: 0
In this case–control study, investigators identified relevant comorbidities among individuals with bullous pemphigoid before and after their diagnoses.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet-
A new study shows that individuals with #BullousPemphigoid prior to diagnosis have greater odds of psoriasis, pressure ulcers, intracerebral hemorrhage, acute renal failure, scabies, drug eruption, and neuropsychiatric disorders. View more: https://t.co/SNXgqNLNaE https://t.co/kMcNQq3oXi
-
-
Mashup Score: 0
In this case–control study, investigators identified relevant comorbidities among individuals with bullous pemphigoid before and after their diagnoses.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet-
A new study shows that individuals with #BullousPemphigoid prior to diagnosis have greater odds of psoriasis, pressure ulcers, intracerebral hemorrhage, acute renal failure, scabies, drug eruption, and neuropsychiatric disorders. View more: https://t.co/SNXgqNLNaE https://t.co/kMcNQq3oXi
-
-
Mashup Score: 0Rituximab, Omalizumab Combination Therapy Well-Tolerated for Bullous Pemphigoid Patients - 2 year(s) ago
This data may bring patients with the rare immunobullous disease closer to an eventual FDA-approved treatment.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet-
New research into rituximab & omalizumab for patients with #BullousPemphigoid points to some notable new findings. Want to learn more? View the story here: https://t.co/YOVtkKcQ2O
-
-
Mashup Score: 0Rituximab, Omalizumab Combination Therapy Well-Tolerated for Bullous Pemphigoid Patients - 2 year(s) ago
This data may bring patients with the rare immunobullous disease closer to an eventual FDA-approved treatment.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet-
New research into rituximab & omalizumab for patients with #BullousPemphigoid points to some notable new findings. Want to learn more? View the story here: https://t.co/YOVtkKcQ2O
-
-
Mashup Score: 0article - 2 year(s) ago
1. IntroductionBullous pemphigoid is an autoimmune subepidermal blistering disorder. Mantle cell lymphoma is a B-cell malignancy of a rare type of non-Hodgkin lymphoma. Bullous pemphigoid associated with mantle cell lymphoma is even rarer which may suggest a paraneoplastic phenomenon.[1]2. Case reportA 29-year-old Malay man, a federal plantation supervisor, was admitted with 5 months’ history of…
Source: journals.lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#BullousPemphigoid, an autoimmune subepidermal blistering disorder, associated with #MantleCellLymphoma, a rare type of non-Hodgkin lymphoma, may suggest a paraneoplastic phenomenon. Read more: https://t.co/qxQdWEHKax #ThisIsBloodCancer #Lymphoma https://t.co/2WHpU77CpP
-
-
Mashup Score: 0article - 2 year(s) ago
1. IntroductionBullous pemphigoid is an autoimmune subepidermal blistering disorder. Mantle cell lymphoma is a B-cell malignancy of a rare type of non-Hodgkin lymphoma. Bullous pemphigoid associated with mantle cell lymphoma is even rarer which may suggest a paraneoplastic phenomenon.[1]2. Case reportA 29-year-old Malay man, a federal plantation supervisor, was admitted with 5 months’ history of…
Source: journals.lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#BullousPemphigoid associated with mantle cell lymphoma (MCL) is very rare. In a case report, diagnosis of bullous pemphigoid led to the detection of #MCL. Early diagnosis is crucial in managing this aggressive type of disease. Read the rare case report: https://t.co/1ckFLW7Ppb https://t.co/qrAOf6fYy3
-
-
Mashup Score: 0
This new data indicates that dupilumab in this patient population had favorable efficacy and safety, though some unique concerns were risk of infection and eosinophilia.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet-
New data suggests dupilumab treatment improves clinical symptoms of #BullousPemphigoid, though concurrent infection/eosinophilia should be considered. View the story: https://t.co/6VNNL9T762 https://t.co/kEfnvTdESj
-
-
Mashup Score: 0
Some patients with the condition may experience exacerbation or new onset.
Source: Dermatology TimesCategories: Dermatology, Latest HeadlinesTweet-
Though rare, some patients with #BullousPemphigoid may experience dramatic exacerbation or new onset of disease following COVID-19 vaccination. https://t.co/uAWQP6V3d7
-
New findings suggest that while serum IL-13 levels are lower in patients with #BullousPemphigoid compared to healthy controls, IL-13 levels do not correlate with bullous pemphigoid severity or prognosis. View more: https://t.co/pvVUOPKNEB